Impact of Primary Kidney Disease on the Effects of Empagliflozin in Patients with Chronic Kidney Disease: Secondary Analyses of the EMPA-KIDNEY trial

Judge P., STAPLIN N., Mayne K., Wanner C., Green J., Hauske S., EMBERSON J., PREISS D., NG S., Roddick A., SAMMONS E., ZHU D., HILL M., STEVENS W., WALLENDSZUS K., Brenner S., Cheung A., Liu Z-H., Li J., Hooi L., Liu WJ., Kadowaki T., Nangaku M., Levin A., Cherney D., Maggioni A., Pontremoli R., Deo R., Goto S., Rossello X., Tuttle K., Steubl D., Massey D., LANDRAY M., BAIGENT C., HAYNES R., HERRINGTON W.

Type

Journal article

Journal

Lancet Diabetes and Endocrinology

Publisher

Elsevier

Publication Date

25/10/2023

Permalink